Previous Article | Next Article 
Molecular and Cellular Biology, December 1999, p. 8513-8525, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Functional Analysis of the DXPas34
Locus, a 3' Regulator of Xist Expression
E.
Debrand,
C.
Chureau,
D.
Arnaud,
P.
Avner, and
E.
Heard*
Unité de Génétique
Moléculaire Murine, URA CNRS 1947, Institut Pasteur, Paris 75015, France
Received 4 May 1999/Returned for modification 7 July 1999/Accepted 25 August 1999
 |
ABSTRACT |
X inactivation in female mammals is controlled by a key locus on
the X chromosome, the X-inactivation center (Xic). The Xic controls the
initiation and propagation of inactivation in cis. It also
ensures that the correct number of X chromosomes undergo inactivation
(counting) and determines which X chromosome becomes inactivated
(choice). The Xist gene maps to the Xic region and is
essential for the initiation of X inactivation in cis.
Regulatory elements of X inactivation have been proposed to lie 3' to
Xist. One such element, lying 15 kb downstream of
Xist, is the DXPas34 locus, which was first
identified as a result of its hypermethylation on the active X
chromosome and the correlation of its methylation level with allelism
at the X-controlling element (Xce), a locus known to affect
choice. In this study, we have tested the potential function of the
DXPas34 locus in Xist regulation and
X-inactivation initiation by deleting it in the context of large
Xist-containing yeast artificial chromosome transgenes.
Deletion of DXPas34 eliminates both Xist
expression and antisense transcription present in this region in
undifferentiated ES cells. It also leads to nonrandom inactivation of
the deleted transgene upon differentiation. DXPas34 thus
appears to be a critical regulator of Xist activity and X inactivation. The expression pattern of DXPas34 during
early embryonic development, which we report here, further suggests
that it could be implicated in the regulation of imprinted
Xist expression.
 |
INTRODUCTION |
In female mammals, one of the two X
chromosomes in each cell becomes transcriptionally inactive early in
embryonic development. This process is known as X inactivation and is
closely associated with cellular differentiation (see reference
22 for a review). The initiation and spread of X
inactivation are dependent on a unique region of the X chromosome, the
X-inactivation center (Xic). The Xic is also thought to be involved in
determining how many (counting) and which (choice) X chromosomes to
inactivate (see reference 2 for a review). The
Xist gene, which lies within the Xic region, encodes a large
nuclear, untranslated RNA that coats the inactive X chromosome at
interphase (5-8). The developmental expression pattern of
Xist suggests a causal role in X inactivation: prior to
inactivation, Xist is expressed at low levels from every X
chromosome in a cell (27), and at the onset of inactivation, steady-state levels of Xist RNA increase and the transcript
coats the X chromosome that will be inactivated. This transition is associated with stabilization of Xist RNA on the X
chromosome that will become inactive (36, 42). The regulated
changes in stability of the Xist transcript and the coating
of the X chromosome are thought to be concomitant with a switch in
promoter use (26). The elements that regulate all of these
changes remain to be defined functionally, however.
Targeted deletions of the Xist gene have demonstrated that
it is essential for inactivation in cis (33, 37),
but since counting is not abolished in these mutants, it has been
suggested that elements outside Xist itself may also be
involved in overall Xic function. Indeed, when a 65-kb region 3' to
Xist exon 6 is deleted, cis inactivation is not
affected but, instead, the deleted X is systematically inactivated upon
differentiation, even in the absence of a second X chromosome
(12). Elements lying outside Xist that have been
proposed to be implicated in the X-inactivation process include the
Xce locus (10), which is known to affect choice
and has been shown to be genetically separable from Xist (37a, 43). Another is the DXPas34 locus, which
lies 15 kb 3' to Xist (13).
The DXPas34 locus is a CpG-rich region consisting of a
SalI site and a neighboring cluster of HpaII
sites lying within a 34-mer minisatellite repeat, which was originally
identified as a result of its unusual methylation profile.
Methylation of DXPas34 is specifically associated with
the active X chromosome and the transcriptionally silent
Xist gene in somatic tissues and differentiated embryonic stem (ES) cells (3, 13). Analysis of this methylation
profile in strains carrying different Xce alleles suggested
a correlation between the Xce allele present in
cis and the methylation status of the region, although the
Xce locus actually maps distal to DXPas34
(37a, 43). Given its proximity to the Xist gene
and its unusual methylation profile, it has been proposed that the DXPas34 region might play a role in regulating
Xist expression and the initiation of X inactivation. The
DXPas34 locus also displays a number of features that are
strongly reminiscent of the differentially methylated regions (DMRs)
frequently found in the vicinity of imprinted genes (38).
Like DXPas34, DMRs show differential methylation between
alleles, occur in or near CpG-rich regions, and are often associated
with blocks of short tandem repeats. Elements involved in the
establishment of imprinted gene expression lie within such DMRs in
several cases. There are also an increasing number of examples where
DMRs overlap with the transcribed region of unusual noncoding RNAs. In
this context, Lee et al. (28) recently described the
presence of an antisense transcript initiating close to the DXPas34 region and stretching as far as the 5' end of
Xist. As part of the study we present here, we show that the
antisense transcription in this region is actually more widespread and
complex than was originally thought.
To investigate the potential role of the DXPas34 locus in
Xist regulation and the initiation of X inactivation, we
have deleted it in the context of yeast artificial chromosome (YAC)
transgenes in ES cells. We have chosen a YAC transgene-based approach
for the ease and rapidity with which transgene mutations can be
generated in yeast. Transgenes containing Xist are known to
function as ectopic Xics when introduced into ES cells
(29-31), provided that they are present as multicopy arrays
(20). Both inactivation of autosomal sequences in
cis around the transgene and inactivation of the single X
chromosome (counting) can be observed in such transgenic male ES cell
lines. This parallels the process seen in XX ES cells, where in vitro
differentiation is accompanied by inactivation of one of the two X
chromosomes. Although single-copy Xist YAC transgenes do not
seem to be able to induce inactivation, they correctly express
Xist prior to differentiation in ES cells (20).
Thus, even single-copy Xist transgenes can be used to study
the effects of a DXPas34 deletion on Xist
regulation prior to inactivation.
Based on the analysis of several different ES cell lines carrying YAC
transgenes with DXPas34 deleted, we demonstrate that this
locus is essential for Xist expression in undifferentiated ES cells and may affect the normally random nature of X inactivation in
ES cells. We also show that the presence of this locus is associated with widespread antisense transcription. Finally, we show that transcription at the DXPas34 locus during early development
is imprinted, suggesting that this locus may play a regulatory role in
the early steps of Xist expression and X inactivation.
 |
MATERIALS AND METHODS |
RT-PCR analysis.
Reverse transcription (RT) was performed on
total RNA isolated with RNAzol B (Bioprobe) and treated with RNase-free
DNase I (Pharmacia; 10 U/µg of RNA) for 30 min at 37°C to destroy
genomic DNA. Genomic DNA contamination artifacts were controlled for in every RT reaction by including a RNA sample where reverse transcriptase was omitted. Random-primed RT was performed on 10 µg of RNA by using
SuperScriptII reverse transcriptase as recommended by the manufacturer
(Gibco-BRL) with random hexamers (Pharmacia) to prime first-strand cDNA
synthesis in a 50-µl reaction mixture. The first round of PCR was
performed on 2 µl of the RT reaction products and involved 40 cycles
with forward and reverse primers under standard PCR conditions with an
annealing temperature of 55°C unless otherwise stated (see Table 1).
The second round of PCR was performed on 1 µl of the first-round
reaction product by using nested primers (see Table 1) and a further 30 cycles of PCR. For strand-specific RT, 20 µg of DNase I-treated total
RNA was divided into five aliquots and reactions were performed in a
50-µl volume for 1 h at 42°C with primers (26pmol) with or
without reverse transcriptase as follows (see Fig. 1C also). The five
aliquots were as follows: 1, forward primer, reverse transcriptase
present, to detect the antisense transcript (with respect to
Xist); 2, forward primer, reverse transcriptase absent; 3, reverse primer, reverse transcriptase present, to detect the sense
transcript; 4, reverse primer, reverse transcriptase absent; 5, no-primer control, reverse transcriptase present. A single round of 40 cycles of PCR was performed on each reaction with nested forward and reverse primers adjacent to the primer used for cDNA synthesis. Sites
further downstream were also tested to detect the extent of the cDNAs
generated. In each case 15 µl of the 50-µl reaction mixture was
loaded onto an ethidium bromide-stained agarose gel.
YAC manipulation and mutagenesis.
The YACs PA-2 and PA-3 F1n
contain extensive sequences 5' (130 kb for PA-2 and 150 kb for PA-3
F1n) and 3' (310 kb for PA-2 and 100 kb for PA-3 F1n) to
Xist and have previously been described in detail
(18-21). Retrofitting of PA-2 and PA-3 F1n with the
Pgk1-neo cassettes and I-PpoI sites (for PA-2
only) has been described previously (15, 20).
DXPas34 was deleted by homologous recombination in yeast.
The pUR and pRA vectors can be used to delete the target sequence by
replacement with a selectable marker (URA3) (16). Regions of homology for targeting of the DXPas34 region were
generated with the following primers, designed from published sequence
(accession no. X99946) (44): primer 34-1, 5'
cgggatccCTTGGTGGCTTAAAGCAACA 3' (positions 13421 to 13440);
primer 34-2, 5' ggggtaccTTCGGAAGAGAAGAAAGATT 3' (positions
13861 to 13842); primer 34-3, 5' cgggatccGGGGCAGAGCTTAGGGGAAC 3'
(positions 16879 to 16898); and primer 34-4, 5'
ggggtaccTTTGCATTGATACTGACTGT 3' (positions 17320 to 17301). The
primers contain a BamHI (34-1 and 34-3) or KpnI
(34-2 and 34-3) 5' extension to enable the subsequent cloning of PCR
products into the pUR and pRA plasmids. PCR was performed with primer
pair 34-1 and 34-2, which amplifies a 441-bp 5' fragment (34-1/2), and
with pair 34-3 and 34-4, which give rise to a 442-bp 3' fragment
(34-3/4). PCR was performed on 100 ng of C3H/He genomic DNA under
standard conditions (16), with an annealing temperature of
55°C. The PCR products were digested with BamHI and
KpnI, and 50 fmol was ligated to equimolar amounts of
BamHI-KpnI pUR (5' PCR product 34-1/2)- or
BamHI-KpnI pRA (3' PCR product 34-3/4)-digested
plasmids. Recombinant plasmids were sequenced to verify the absence of
mutations prior to their introduction into the YACs. The pUR-34-1/2
(homology 5' to DXPas34) and pRA 34-3/4 (homology 3' to
DXPas34) plasmids were linearized with NotI, and
5 µg of each fragment was cotransformed into YAC PA-2 or PA-3
F1n-containing AB1380 yeast spheroplasts (40).
URA+ transformants were selected for in complete synthetic
medium lacking uracil (SD COM-Ura) and then replica plated onto SD
COM-Trp-Lys-Ura (PA-2) or SD COM-Trp-Lys-His-Ura (PA-3 F1n) to
eliminate clones which had lost only one of the selectable markers
present in the YAC arms and were unlikely to represent true
recombinants. Agarose plugs of yeast genomic DNA were prepared, and
pulsed-field gel electrophoresis (PFGE) and Southern blot analysis of
YAC clones were performed as previously described (19).
Seven PA-2 clones (35%) and four PA-3 F1n clones (22%) were obtained
that had retained an intact YAC (460 and 320 kb, respectively) which
was positive for the URA3 gene (URA probe generated by
HindIII/NotI digestion of pUR vector). The
use of primers URA34f (5' GTTTCTTCCTCCAATGTAAT 3') and
URA34r (5' CCATTCTTTTCTGTGACTCC 3'), which should amplify a
1.5-kb fragment from the correctly deleted and URA3-replaced region, allowed initial characterization of deletion clones. Southern analysis of recombinant clones, following EcoRI,
EcoRI-SalI, and EcoRI-EagI
DNA digestion, enabled a more detailed assessment of the structure of
the deletion. The overall structure of the YACs was verified by
hybridization of various probes lying in and around the Xist
gene to EcoRI- and HindIII-digested DNA (see
Fig. 3).
Generation and characterization of transgenic ES cell lines.
YAC DNA was purified and lipofected into CK35 ES cells (9),
as previously described (20). Neor clones were
selected 24 h after YAC transfer by G418 treatment (0.25 mg/ml).
Agarose plugs of genomic DNA from transgenic and control ES cells were
prepared as described previously (20). I-Ppo-I
digestion of agarose-embedded DNA from YAC PA-2
34.1-derived lines
was performed as specified by the manufacturer (Promega). Southern
analysis of EcoRI- or HindIII-digested DNA
from YAC PA-2
34.1- and YAC PA-3 F1n
34.3-derived lines was
carried out by standard procedures. The transgene copy number was
quantitated by PhosphorImager analysis (Molecular Dynamics) of blots
hybridized with a Xist probe (nucleotides 5379 to 5547)
together with an X chromosome probe Xpct (probe 128E2) which
does not lie within the YACs (14). Normalization of
Xist versus Xpct signals was performed with male
and female controls and other YACs containing both Xist and
Xpct genes (14).
Culture and differentiation of ES cells.
Male CK35 and
female HP310 ES cells (20) and transgenic ES cell
derivatives were maintained in the undifferentiated state by culture in
ES cell medium (Dulbecco's modified Eagle's medium [DMEM], 4.5 g of glucose per liter, 2 mM glutaMAX I [Gibco-BRL], 0.1 mM
2-mercaptoethanol, 15% fetal calf serum (Gibco-BRL), 103 U
of recombinant leukemia inhibitory factor (LIF) [Gibco-BRL] per ml,
0.05 mg of streptomycin per ml, 50 U of penicillin per ml) on mitomycin
C-treated mouse fibroblast feeder cells with appropriate G418 selection
for transgenic cells. For differentiation into embryoid bodies (EBs),
feeders were first removed by successive adsorptions on gelatinized
dishes and then cultivated for 3 days under adherent conditions in ES
cell medium (39). Aggregates were formed following mild
trypsinization and transferred to suspension culture (day 0) in EB
medium (DMEM, 10% newborn calf serum, 0.1 mM 2-mercaptoethanol, 2 mM
glutaMAX I, antibiotics [as above]) without G418 selection.
Four-day-old EBs were attached to LabTek chamber slides (Nunc) for
monolayer outgrowth for 3 to 8 days in DMEM-2mM glutaMAX
I-antibiotics (as above)-10% fetal calf serum.
Embryo preparation for RNA fluorescent in situ hybridization
(FISH).
Preimplantation embryos were flushed from the oviducts or
uterus and the zona pellucida was removed as described previously (25). Postimplantation embryos were dissected from maternal tissue and Richert's membrane and the ectoplacental cone were removed
as described previously (4). Embryo collection was performed
in M2 medium (25). Embryos of 3.5, 6.5, and 7.5 days postcoitum (p.c.) were disaggregated in trypsin-EDTA. Whole (
3.5 days p.c.) or disaggregated embryos were transferred in 100 µl of
DMEM-10% fetal calf serum to siliconized cytofunnels and collected on
Superfrost Plus glass slides (BDH) by cytocentrifugation at 600 to 800 rpm (Shandon Cytospin 3) for 4 min. Embryo slides were fixed and stored
as described below for ES cells.
DNA and RNA FISH analysis on ES cells and EBs.
Cells grown
on chamber slides or cytocentrifuged (4 min at 400 rpm) onto baked
glass slides were permeabilized with Triton X-100 in ice-cold
cytoskeletal buffer for 7 min and fixed with 4% paraformaldehyde for
10 min on ice; they were then stored in 70% ethanol at 4°C. ES cells
and EBs were prepared for RNA and DNA FISH as described previously
(20). For RNA FISH, the slides were dehydrated and used
directly for hybridization. For DNA FISH, nuclei were denatured for 2 min in 70% formamide-2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M
sodium citrate) at 75°C, while for simultaneous RNA and DNA FISH,
nuclei were denatured for just 1.5 min. The hybridization and washing
conditions were as described previously (11). Nuclei were
mounted in Vectashield (Vector) and counterstained with
4',6-diamidino-2-phenylindole (DAPI). A Quantix charge-coupled device
camera and IPLab and Photoshop software were used for image acquisition
and treatment. Probes were labelled either by nick translation (Vysis)
with Spectrum Green-dUTP or Spectrum Red-dUTP (Vysis) or by biotin
incorporation via random priming (Gibco-BRL). Biotinylated probes were
detected with fluorescein avidin (Vector) or Texas red avidin (Vector). Amplification of signal, when used (at sites 11 to 15), involved one
layer of biotinylated anti-avidin (Vector) followed by another layer of
fluorescein avidin or Texas red avidin. The Xist probes were
510 (41), which covers 20 kb of the Xist
gene, mx8 (26), which covers 5 kb between the
Xist P0 and P1 promoters, and mx7 (26), which
covers 7 kb within Xist exon I. The DXPas34 probe was a plasmid obtained by cloning of the 3.2-kb PCR product amplified from C3H/He mouse genomic DNA with primers URA34 for and URA 34 rev
(see "YAC manipulation and mutagenesis" above) in pGEM-T easy (Promega). Probes corresponding to sites 1 to 15 were generated by
pGEM-T-cloning of PCR products amplified from genomic DNA with the
primers listed in Table 1.
Strand-specific probes were either single-stranded phage DNA
corresponding to mx8, isolated from pBluescript as recommended by
Stratagene and verified for template specificity by Southern
hybridization with radioactively end-labelled oligonucleotides, or
pools of 50-mer fluorescein-labelled oligonucleotides, corresponding to
sequences within Xist exon I, synthesized by Eurogentec. The
YAC-specific probe was pYAC4 vector DNA. The X chromosome-specific
probe (BAC X) was a BAC isolated by using the microsatellite marker
DXMit158; it lies outside the X chromosome region covered by
YACs PA-2 and PA-3 F1n.
 |
RESULTS |
RT-PCR analysis of transcription in the Xist-DXPas34
region in ES cells.
To identify potential transcripts associated
with the DXPas34 locus, RT-PCR and Northern analysis of RNA
from ES cells and adult tissues were performed. Initial results
suggested the presence of multiple, low-level transcripts mainly in the
antisense orientation (based on riboprobe analysis) with respect to
Xist, which included but extended beyond the
DXPas34 locus (data not shown). To examine this low-level
transcription pattern further, RT-PCR analysis was carried out at 21 positions (primer positions are given in Fig.
1 and Table 1) in a region spanning just
over 50 kb and including Xist and
DXPas34. In undifferentiated XX and XY ES cells, when
random-primed RT followed by a single round of PCR was performed, RT
products were detected from MX3 (a site lying between Xist promoters P0 and P1) through to site 10 (within DXPas34).
When a second (nested) round of PCR was performed, widespread
transcription was observed across the whole 50-kb region tested. The
results are summarized in Fig. 1B. When strand-specific RT-PCR was
carried out with undifferentiated XX ES cells, using sense or antisense primers from site MX3 through to site 15, antisense transcription was
detected at all positions (Fig. 1C). This technique is apparently more
sensitive than random-primed RT, since RT products could be detected
after just a single round of PCR. Sense transcription, in addition to
antisense transcription, was seen within Xist (site X1
through to site 1 [Fig. 1C]) as expected. Occasional sense transcripts were also found 3' to Xist (site 3 [Fig. 1C]
and site 4 [not shown]).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Map of the 50-kb region containing the
Xist gene (exons shown as solid boxes) and the
DXPas34 locus (which includes the 34-mer minisatellite
repeat shown). Shaded bars above the map represent probes mx8, mx7, and
DXPas34, used for RNA FISH. The positions of all the sites
tested by RT-PCR are shown beneath the map as dots. Each dot represents
the primer pairs used for RT-PCR analysis (for sequences of both outer
and inner nested primer pairs, see Table 1). Lines below the map
represent antisense transcript continuity: first-strand antisense cDNA
was synthesized by using a sense primer (shown as an arrowhead below
the appropriate site) and then amplified with primer pairs at sites
downstream. Each line represents the extent of positive amplification
obtained for the cDNA in question. (B) Summary of the RT-PCR data
obtained by using random hexamers to prime cDNA synthesis. Control
samples where reverse transcriptase was omitted were always included to
rule out possible genomic DNA contamination. The results were assessed
by using ethidium bromide-stained gels. Undifferentiated male and
female ES cells gave identical results. Differentiated female ES cells
represent 10-day EBs. Differentiated male ES cells gave identical
results, apart from sites within Xist and site 2, which were
negative after a single round of PCR. Somatic tissues tested were adult
brain and in some cases liver. Male and female adult tissues gave
identical results apart from site 2 (as above) and site MX3, which was
positive in male but not in female cells. (C) Strand-specific RT-PCR
analysis. (Top) Summary of the data; (bottom) representative sample of
the data is shown. Antisense transcription was detected at all 20 sites
from MX3 through to site 15 in undifferentiated ES cells. Sites X1
through to 1 within Xist also showed sense transcription.
Sense transcripts were also detected at sites 3 and 4. (a) At MX3,
sense transcript was only faintly, and not systematically, detected. In
adult brain, sites X3, 4, 5, and 8 were tested and all showed antisense
transcription. (b) Sense transcript was detected within Xist
at X3 in females but not in males. cDNA synthesized from antisense
transcript (AS) at each site was primed by using the sense primer, and
cDNA synthesized from sense transcript (S) was primed by using an
antisense primer. Lanes: 1, AS plus reverse transcriptase; 2, AS minus
reverse transcriptase; 3, S plus reverse transcriptase; 4, S minus
reverse transcriptase; 5, reverse transcriptase without any primer; 6, H2O control; 7, genomic DNA control. The specificity of the
RT reactions was controlled by including an RNA sample where no primer
was present (lane 5).
|
|
The continuity of the transcript(s) in this region was also assessed.
RT was initiated at single sites on the RNA with strand-specific
primers, and the extent of the resulting cDNA was examined by
PCR with
primers at various sites downstream of the primer used
for first-strand
synthesis (a summary of these results is given
in Fig.
1A). Within the
Xist gene itself, antisense transcript
continuity appeared
to be extensive. For example, when primer
X2F was used to prime cDNA
synthesis from antisense RNA, sites
up to 12 kb away (i.e., as far as
site 1 [Fig.
1A]) were positive
by PCR. Downstream of
Xist, the continuity of antisense transcripts
detected was
more variable, particularly in the vicinity of the
DXPas34
region (Fig.
1A). For example, cDNAs initiated with primers
at sites 3 and 6 extended only up to 4 kb (site 8) and 6.5 kb
(site 13) away,
respectively. This could be a result of the inefficiency
of the reverse
transcriptase in extending across certain sequences.
Alternatively, it
could be an indication that multiple transcripts
of variable length are
present in this
region.
We also examined transcription in differentiated ES cells and adult
tissues. As expected from previous work (
27), RT products
were seen within
Xist after just a single round of random
primed
RT-PCR in differentiated female (Fig.
1B) but not male (not
shown)
ES cells and adult brain. Transcription detected at site 2, just
3' to
Xist exon 8, in females probably represents runthrough
transcripts
from the 3' end of
Xist. Some low-level
transcription was, however,
detected at several sites in both male and
female differentiated
cells following nested, random primed RT-PCR.
This was seen in
two domains, one across
Xist and the other
around
DXPas34, separated
by a gap at site 3 (Fig.
1B).
Strand-specific RT-PCR performed
at a number of sites revealed this
low-level transcription to
be antisense (Fig.
1C).
We conclude that widespread, low-level antisense (and occasional sense)
transcription occurs in undifferentiated ES cells,
across a region
covering at least 50 kb and including
Xist and
DXPas34. Transcripts within the 40-kb region spanning
Xist and
DXPas34 appear to be more readily
detectable than in the flanking
regions. In differentiated ES cells and
adult tissues, low-level
antisense transcription is also present but
appears to be more
restricted, covering an approximately 23-kb domain
centered on
Xist and a 5-kb domain over
DXPas34.
RNA FISH analysis of transcription in the DXPas34
region in ES cells and early mouse embryos.
Using the
complementary approach of FISH, we were able to assess the proportion
of ES cells expressing transcripts in the DXPas34 region and
also to examine the kinetics of this expression upon differentiation. A
3.2-kb probe covering the DXPas34 locus was used to
examine DXPas34 transcription in undifferentiated male
(CK35) and female (HP310) ES cells, as well as in male ES cells
carrying a two-copy 460-kb Xist YAC transgene (L412)
(20). In undifferentiated ES cells, the Xist
transcript, present in unstable form at every Xist locus, is
detected by RNA FISH as a punctate signal (pinpoint) at its site of
synthesis (36, 42). Using dual-color RNA FISH, we found that
the DXPas34 RNA signal consistently colocalized with the
punctate RNA signal at the Xist locus (
510) in
undifferentiated ES cells (>90%, n > 500) (Fig. 2A). Probes corresponding to cloned PCR
products from sites 2 through 10 (Fig. 1A) gave
similar profiles to the 3.2-kb DXPas34 probe. RNA signal
could not be detected with probes corresponding to sites 11 through 15, although following amplification (see Materials and Methods), faint
signals could occasionally be seen (data not shown). This is consistent
with our random primed RT-PCR data suggesting that transcription in the
region distal to DXPas34 is present at lower levels or is
less readily detectable. Finally, in undifferentiated male, female, and
transgenic ES cells, DXPas34 transcripts were found to
colocalize with both sense and antisense transcripts at the
Xist locus (mx8 and Xist exon I [Fig. 1A]; see
Materials and Methods), as expected from our RT-PCR analysis and
previously published data (28) (Fig. 2G to L).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 2.
Two-color RNA FISH analysis of ES cells and
preimplantation mouse embryos. (A to E) RNA FISH on XX ES cells with a
Xist ( 510) probe (green) and the 3.2-kb
DXPas34 probe (red). Overlapping green and red signals are
seen as yellow. (A) Undifferentiated XX ES cell showing colocalization
of Xist and DXPas34 punctate signals. (B)
Differentiating XX ES cell displaying an immature Xist RNA
domain containing a DXPas34 signal on one X and a
Xist/DXPas34 punctate signal on the other. (C)
Differentiating XX ES cell displaying an immature Xist RNA
domain without a DXPas34 signal. (D) Differentiating XX ES
cell with a mature Xist RNA domain and no DXPas34
signal within it. (E) Fully differentiated XX ES cell with a mature
Xist RNA domain and no DXPas34 signal on either
X. (F) Frequency of cells exhibiting different patterns of
Xist and DXPas34 RNA signals in XX ES cells and
EBs at different times of differentiation in days (d). Xist
RNA punctate signals (detected by 510) are shown as white
pinpoints, and DXPas34 RNA signals are shown as black
pinpoints. Immature Xist RNA domains are shown as light grey
ovals. Mature Xist RNA domains are shown as dark grey ovals.
Cell numbers scored were 1 day (n = 56), 2 days
(n = 116), 3 days (n = 100), 4.5 days
(n = 85), and 7 days (n = 78). A small
proportion of cells (<5%), showing either two Xist
pinpoints and only one DXPas34 pinpoint or vice versa (and
no Xist RNA domain), which were detected at every stage, are
not included in the histogram. (G to L) RNA FISH on XY and transgenic
XY ES cells by using strand-specific Xist probes mx8 or exon
I oligonucleotides (green) and the 3.2-kb DXPas34 probe
(red). (G) Undifferentiated male ES cell. The Xist sense
transcript colocalizes with the DXPas34 transcript. (H)
Undifferentiated male ES cell. The Xist antisense transcript
colocalizes with the DXPas34 transcript. (I)
Undifferenitated female ES cell. Sense transcripts at both
Xist alleles colocalize with DXPas34 transcripts.
(J) Undifferentiated female ES cell. Antisense transcripts at both
Xist alleles colocalize with DXPas34 transcripts.
(K) Undifferentiated male ES cell containing a two-copy YAC PA-2
transgene (L412). The Xist sense transcript colocalizes with
the DXPas34 transcript. (L) Undifferentiated L412 ES cell.
The Xist antisense transcript colocalizes with the
DXPas34 transcript. Note that in panels K and L, one allele
(previously shown to be the two-copy transgene [20])
gives a slightly larger signal than the other. (M to P) RNA FISH on
male and female blastocysts by using a Xist ( 510) probe
(green) and the 3.2-kb DXPas34 probe (red). Smaller probes
from the DXPas34 region (sites 2, 3, 6, and 9) gave similar
profiles to the larger DXPas34 probe. (M) Male blastocysts.
In a proportion of cells, a Xist/DXPas34 RNA pinpoint signal
is detected on the maternal X chromosome. (N) Female blastocysts. Most
cells contain a Xist RNA domain corresponding to the
paternal X with no sign of DXPas34 RNA within such domains.
A proportion of these cells also contain a Xist/DXPas34 RNA
pinpoint signal. (O) A small proportion of female blastocyst cells,
probably corresponding to the ICM, contains no Xist RNA
domain, and either one or two Xist/DXPas34 RNA pinpoint
signals. (P) Frequency of the different patterns of
Xist/DXPas34 expression observed in morulas and
blastocysts.
|
|
We next investigated the kinetics of
DXPas34 and
Xist transcription in differentiating ES cells (data
summarized in Fig.
2F).
When XX ES cells are differentiated in vitro,
Xist transcripts
are stabilized and accumulate over the X
chromosome to be inactivated,
forming a "domain" of
Xist
RNA. In fully differentiated XX ES
cells,
DXPas34
transcription was found to be absent from such
Xist RNA
domains (Fig.
2E). At early stages of differentiation,
(Fig.
2A to D),
a
Xist RNA domain (prospective inactive X) in
addition to a
punctate
Xist signal on the active X was seen in
an
increasing proportion of cells.
DXPas34 RNA was associated
only with the punctate
Xist signal and not with domains in
the
majority of such cells (Fig.
2A to D). Occasionally, however,
a
DXPas34 RNA pinpoint was seen within larger
Xist
RNA signals
that appeared to correspond to "immature" domains
(e.g., day 2,
6%,
n = 116) (Fig.
2B). Down-regulation
of
DXPas34 transcription
thus seems to be tightly correlated
with the onset of
Xist RNA
coating of the X chromosome to be
inactivated but does not actually
precede it. On the active X in both
male and female ES cells,
DXPas34 transcription disappeared
as differentiation proceeded,
as did the punctate
Xist RNA
signal (Fig.
2E). Similar results
were obtained with transgenic (L412)
ES
cells.
We also examined
DXPas34 transcription in early mouse
embryos by RNA FISH. In preimplantation female embryos, the paternally
derived X chromosome is coated by
Xist RNA from at least the
eight-cell
stage, while the maternal
Xist allele is seen as
a punctate signal
and is present in only a proportion of cells
(
42). This pattern
may underlie the preferential
inactivation of the paternal X,
which occurs later, in extraembryonic
tissues. In the earliest
embryos examined (early morulas, 8 to 16 cells), we detected a
DXPas34 RNA signal which colocalized
consistently with the
Xist punctate signal on the maternal X
but never with the
Xist RNA
domain over the paternal X (Fig.
2M and N). Strand-specific probes
at the
Xist locus showed
that both sense and antisense
Xist RNA
pinpoint signals
colocalized with the
DXPas34 signal (data not
shown). At a
later stage, in female blastocysts, a small proportion
of cells which
contained one or two
Xist/DXPas34 RNA punctate
signals and
no
Xist RNA domains were also observed (Fig.
2O).
These
presumably corresponded to inner cell mass (ICM) cells destined
to form
the embryo. The data are summarized in Fig.
2P. In postimplantation
(6.5 and 7.5 days p.c.) embryos,
DXPas34 transcripts always
colocalized
with
Xist RNA pinpoints on the active X (data
not shown). In female
embryos, as in differentiating XX ES cells (see
above), occasional
cells were observed with a
DXPas34 RNA
signal within an immature
Xist RNA domain (as in Fig.
2B)
but never within mature
Xist RNA
domains. In summary,
transcription at the
DXPas34 locus seems
to be imprinted and
to correlate with the low-level expression
of the maternal
Xist gene seen in preimplantation
embryos.
Deletion of the DXPas34 locus in YACs and generation of
ES lines carrying
DXPas34 YAC transgenes.
The
unusual methylation profile of the DXPas34 locus
(13), given its proximity to the Xist gene,
provided circumstantial evidence for a role for DXPas34 in
the regulation of Xist expression and X inactivation. The
antisense transcription detected across the DXPas34 region
was also suggestive of some function for this locus. To address this
question directly, we deleted the DXPas34 locus in the
context of two different YACs, PA-2 (460 kb) and PA-3 F1n (320 kb)
(Fig. 3A). Both YACs have previously been
shown to carry out aspects of Xic function when introduced at ectopic sites by transgenesis (20). A 3,016-bp region (Fig. 3B)
which encompasses the GC-rich HpaII-containing 34-mer repeat
array and the SalI site 5' to it (see Materials and Methods)
(13) was targeted by using a combination of two replacement
vectors (see Materials and Methods). Homologous recombination resulted
in this 3-kb region being replaced by a 1.3-kb fragment containing the yeast URA3 gene (Fig. 3B). Two of the DXPas34
deletion YACs obtained, PA-2
34.1 and PA-3 F1n
34.3, were
analyzed in detail to verify that their overall structures were correct
(Fig. 3C). The expected deletion and replacement of DXPas34
was ascertained in this way. No rearrangements could be detected within
or around the Xist gene by Southern blot analysis of these
clones (see Materials and Methods).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
Structural analysis of the DXPas34 deletion
in YACs PA-2 and PA-3 F1n. (A) Structures of the two YACs used for the
deletion of DXPas34, PA-2 (460 kb), and PA-3F1n (320 kb).
The DNA probes, in and around the Xist gene, used to
characterize the YACs and transgenic clones are shown as solid boxes
along with the I-PpoI (PA-2 only) and SalI
(Sa) sites that were informative in the analysis of the
transgenes. (B) Structure of the DXPas34 locus before and
after deletion. The 4.6-kb EcoRI fragment containing
DXPas34 in the undeleted YACs and the structure of the same
region after the deletion of DXPas34 and replacement with
the URA3 yeast gene are indicated. A solid box above the map
represents the extent of the 3-kb DXPas34 deletion, and
dashed lines indicate the correspondence between the EcoRI
sites of the intact and the deleted ( DXPas34) sequences.
EcoRI (E), HpaII (H),
MluI (M), EagI (Ea), and
SalI (Sa) indicate restriction sites used for the
structural analysis of this region. The sizes of informative
EcoRI-SalI and EcoRI-EagI
fragments are shown. Probes (a, b, c, and URA) used to assess the
structure of the region, following homologous recombination, are shown
as open boxes below each map. The region containing probe c disappears
following the replacement of DXPas34 by the yeast URA3 gene
(open box). Transcriptional orientation of URA3 is shown by an arrow
(5'-3'). (C) Example of Southern blot analysis with probes a, b, c, and
URA on YAC PA-2 34.1 DNA compared to the parental undeleted YAC PA-2
DNA. EcoRI (E), EcoRI-SalI
(E/Sa), and EcoRI-EagI
(E/Ea) informative digests were used to demonstrate the
disappearance of a SalI site and the region containing probe
c, concomitant with the replacement by the URA3 and a new
EagI site (B). Probe a detects 4.6-kb (undeleted), 2.9-kb
( DXPas34), and 1.7-kb EcoRI fragments, the last of these
corresponding to the additional restriction fragment recognized by this
probe which overlaps an EcoRI site (B). Similar results were
obtained when this analysis was performed on YAC PA-3 F1n 34.3 and
parental YAC PA-3 F1n DNAs (data not shown).
|
|
YACs PA-2

34.1 and PA-3 F1n

34.3 were then transferred into CK35
XY ES cells by lipofection of purified DNA and transgenic
clones
isolated as previously described (
20). The structural
integrity of the YAC PA-2

34.1 transgenes was verified by
I-
PpoI
digestion of DNA of the PA-2

34.1 transgenic ES
cell clones,
since sites for the meganuclease I-
PpoI had
been previously introduced
into each arm of this YAC (Fig.
1A)
(
15,
20). In addition,
SalI PFGE Southern blot
analysis was performed (data not shown).
The integrity of YAC PA-3 F1n

34.3 transgenes was assessed by
SalI PFGE Southern blot
analysis (
20). Four PA-2

34.1-containing
lines (LP1, LP5,
LP6, and LP17) and one PA-3 F1n

34.3-containing
line (LF1) were
chosen for further study based on the integrity
of their transgenes as
evaluated by such PFGE analysis. The transgene
copy number of the lines
obtained was assessed by Southern blot
analysis of
EcoRI-digested ES cell DNA. Simultaneous hybridization
of
various
Xist probes and of another X chromosome probe
(
Xpct),
not contained within the YACs (
14),
allowed copy number quantification
by PhosphorImager analysis. The YAC
copy number was estimated
to range in these lines from 1 to 3-4 (Table
2).
DXPas34 transgenes show absence of transcription
across the Xist-DXPas34 region in undifferentiated ES
cells.
Single-copy and multicopy YAC transgenes have previously
been shown to express the Xist transcript in its unstable
form in undifferentiated ES cells (20, 31). When RNA FISH is
used, two Xist pinpoints corresponding to the transgenic
locus and the X chromosome are normally observed in undifferentiated
male transgenic ES cell lines. The size of the transgenic
Xist transcript signal appears to correlate with copy number
(20, 31).
To determine whether the expression profile of
Xist was
affected by the deletion of
DXPas34 in undifferentiated
cells, the
five transgenic lines (Table
2) were examined by RNA FISH.
In
all the lines carrying a
DXPas34 YAC transgene, only a
single
RNA pinpoint per cell was observed at the
Xist locus
(

510 probe,
93%,
n > 1,000) (Fig.
4B-D). This contrasts with the result for
the L412 line, which carries two intact copies of the parental
YAC
PA-2, where two pinpoints per nucleus were observed in 92%
of cells
(
n > 500), and one of these pinpoints (corresponding
to the transgene) was consistently larger than the other (Fig.
4A; see
also Fig.
2H to I). DNA FISH with a YAC-specific (pYAC4)
probe
confirmed that these
DXPas34 cells with only one
Xist RNA
pinpoint were actually transgenic (>95%,
n > 500) (data not shown).
To determine whether the
unique RNA signal at the
Xist locus observed
in
DXPas34 lines was derived from the transgene or the X
chromosome,
YAC-specific (pYAC4) DNA FISH was performed following
Xist RNA
FISH detection (shown in Fig.
4E for line LP6). The
RNA pinpoint
was consistently found to colocalize with the X chromosome
rather
than with the transgene. Furthermore, dual-color RNA FISH with
a
Xist (

510) probe together with a
DXPas34
probe corresponding
to the deleted region in the
DXPas34
transgene revealed 100%
colocalization of the

510 and
DXPas34 RNA signals (
n > 1,000),
again
demonstrating the X chromosome origin of the unique
Xist/DXPas34 RNA pinpoint. Since the
Xist RNA
signal derived from the undeleted
two-copy YAC PA-2 transgene present
in L412 cells was actually
often more intense than the X chromosome
signal, total absence
of
Xist RNA signal in the
DXPas34 lines carrying up to four YAC
copies was unlikely
to be due to inefficient detection.

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 4.
Xist and DXPas34 expression in ES
cell lines with intact or DXPas34 YAC transgenes. (A to
D) Dual-color RNA FISH, with Xist ( 510, green) and
DXPas34 (red) probes, was performed on undifferentiated ES
cells without denaturation of nuclei. Colocalization of green and red
signals results in the appearance of yellow signals. (A) Control
transgenic male line L412, which carries two copies of YAC PA-2.
Xist and DXPas34 probes detect two colocalized
signals, the larger one having been previously shown to be associated
with the multicopy transgenic locus (20). (B to D) Line LP5
(which contains two or three copies of YAC PA-2 34.1) (B), line LP6
(which contains one copy of YAC PA-2 34.1) (C), and line LF1 (which
contains three or four copies of YAC PA-3 F1n 34.3) (C) all exhibit
a unique Xist/DXPas34 RNA signal. The presence of two
closely associated pinpoint signals represents a replicated locus. (E)
An example of the X chromosomal origin of the unique Xist
RNA pinpoint in the LP6 representative undifferentiated ES cell line.
The Xist RNA FISH signals in positioned nuclei were
photographed, and the slides were then denatured and DNA FISH with a
transgene-specific (pYAC4) probe was performed. This experiment clearly
demonstrates that the single Xist RNA signal (green)
observed in DXPas34 transgenic cell lines prior to
differentiation is not associated with the transgenic locus (red) and
must therefore correspond to the X chromosome. (F to K) Study of the
transcription in the region 3' to Xist with probes
corresponding to sites 2 (F to H) and 3 (I to K) (see Fig. 1A for probe
positions) in control and DXPas34 lines. Double RNA FISH
with a Xist probe (green) and probes from site 2 or 3 (red)
was performed. Line L412 (F) exhibits two Xist-site 2 colocalized signals per nucleus, whereas two representative
DXPas34 transgenic ES cell lines, LP6 (YAC PA-2 34.1)
(G) and LF1 (YAC PA-3F1n 34.3) (H), exhibit only a single
Xist/site 2 signal. Identical results were obtained with the
Xist/site 3 probe combination, on the same lines: L412 (I),
LP6 (J), and LF1. (K). (L and M) Capacity of DXPas34
multicopy YAC transgenes to trigger Xist RNA coating of an
autosome in cis. Simultaneous RNA and DNA FISH was performed
on differentiated cells from the LP5 (L) and LF1 (M) lines with a
Xist probe ( 510; green) and a transgene-specific probe
(pYAC4). Formation of Xist RNA domains is observed on the
autosome carrying the transgene in both lines. (N) Upon
differentiation, transition to Xist RNA coating of an
autosome in cis appears to be correctly regulated in the
multicopy LF1 line: an mx8 probe (green), specific for Xist
transcripts initiating upstream of P1/P2 (from the putative P0
promoter), detects only a single punctate signal per cell, while
Xist RNA domain formation on the transgene is associated
only with an mx7 (Xist exonI) signal (red).
|
|
To study whether deletion of
DXPas34 affected the expression
of the transcript(s) identified in the region 3' to
Xist
(see
above), dual-color RNA FISH was performed with probes
corresponding
to cloned products from sites 2 and 3 (Fig.
1A) together
with
a
Xist (

510) probe on two representative transgenic
lines (LP6
and LF1 [Fig.
4F to K]). In undifferentiated L412 cells
(intact
YAC PA-2), two RNA signals were clearly detected with each of
these probes, and they both colocalized with the two
Xist
locus
RNA pinpoints originating from the X chromosome and from the
transgene
(
n = 44, probe at site 2;
n = 34, probe at site 3 [Fig.
4F and
I]). In contrast, only a single
RNA signal was detectable when
these probes were used in
DXPas34 transgenic lines. For example,
with a probe at
site 2, the RNA signal was always associated with
the unique
Xist pinpoint from the X chromosome and was never associated
with the
DXPas34 transgene in lines LP6 (
n = 69 [Fig.
4G]) and
LF1 (
n = 87 [Fig.
4H]).
Similar results were obtained with sense
and antisense probes which
detect
Xist transcripts upstream of
the P1/P2 promoter (mx8
[Fig.
1A and data not shown]).
Taken together, our data suggest that in undifferentiated ES cells the
deletion of
DXPas34 either eliminates or at least (within
the limits of sensitivity of FISH analysis) drastically reduces
the
transcriptional activity of a large region encompassing
Xist itself and a 15-kb region 3' to
it.
Capacity of
DXPas34 transgenes to inactivate in
cis and to induce counting.
One of the potential
effects of the DXPas34 deletion might be to interfere with
the capacity of the transgene to initiate cis inactivation.
When induced to differentiate in vitro, ES cells carrying multicopy
Xist transgenes can undergo X inactivation; the first sign
of this is coating of the autosome with Xist RNA. This is
detected by RNA FISH as a large nuclear "domain" of Xist RNA (20, 31). When multicopy transgenic lines LP5 (two or three copies) and LF1 (three or four copies) were differentiated in
vitro, Xist RNA domains originating from the transgene were readily observed by simultaneous RNA and DNA FISH (see Materials and
Methods) with the
510 (Xist) and pYAC4
(transgene-specific) probes (Fig. 4L to M). Thus, deletion of
DXPas34 does not interfere with the capacity of multicopy
transgenes to lead to Xist RNA coating and initiation of
inactivation in cis.
Prior to inactivation,
Xist transcription has been reported
to initiate up to 6.5 kb upstream of the somatic promoters P1
and P2,
from a putative P0 promoter. A switch to the P1 and P2
promoters occurs
at the
Xist allele on the X chromosome to be
inactivated at
the onset of X inactivation, and this coincides
with the production of
Xist stable transcripts which accumulate
in
cis
(
26). To determine whether this change in promoter use
occurs normally on the
DXPas34-linked
Xist
allele upon differentiation,
transcription was examined with probes
upstream (mx8) and downstream
(mx7) of the P1 and P2 promoters (Fig.
1A) (
26). In undifferentiated
cells of the multicopy
DXPas34 transgenic lines LF1 and LP5,
no signal was
observed from the
DXPas34 transgenes when either
mx7 or
mx8 was used. In differentiating cells, the
Xist RNA species
coating the autosome was detected only with probe mx7; it was
never
detected with upstream probe mx8, even in cells where the
formation of
a domain has just been initiated (
n = 62) (Fig.
4N).
We
conclude that even when the mx8 region upstream of
Xist is
not transcribed prior to differentiation as a result of the
DXPas34 deletion (see above), the transition to P1- and
P2-directed expression
at the onset of inactivation is correctly
regulated. Thus, deletion
of
DXPas34 does not disrupt
Xist expression in a constitutive
fashion.
In every multicopy
Xist transgenic ES cell line described to
date,
Xist RNA decoration of the single X chromosome was
found
to occur in a proportion of cells. This has been taken to
indicate
that the counting process is being triggered. In transgenic
line
L412, which contains two copies of wild-type YAC PA-2, or L117,
which contains multiple copies of YAC PA-3 F1n, the X chromosome
was
found to be affected in 7 and 10%, respectively, of differentiated
cells with
Xist RNA domains (
20). We set out to
determine whether
DXPas34 transgenes were still capable
of inducing inactivation
of the X chromosome. Simultaneous RNA and DNA
FISH with either
Xist (

510)-plus-pYAC4 or
Xist (

510)-plus-BAC X probe combinations
was performed
on differentiated ES cells to establish whether
Xist RNA
domains were produced by the unique X chromosome in the
multicopy lines
LF1 and LP5. An X chromosome-derived
Xist RNA
domain was
never observed in cells differentiated for 7 days (
n > 500), suggesting that the deletion of
DXPas34 in YAC
transgenes
may lead to skewed inactivation in favor of the
transgene.
 |
DISCUSSION |
In this study we provide functional evidence that the
DXPas34 locus, situated 15 kb 3' to the Xist
gene, is a regulator of Xist expression and propose that it
may play a key role in controlling the initiation of X inactivation. We
also provide evidence that widespread antisense transcription across a
large region including Xist and DXPas34 appears
to be intimately linked to the function of DXPas34.
The DXPas34 locus was deleted in the context of two large
YACs, which were then used as transgenes in male ES cells. Transgenes containing the Xist gene and an intact DXPas34
locus have previously been found to show correct Xist
expression prior to differentiation (20, 30, 31). In
differentiated cells, such transgenes can lead to cis
inactivation and counting when present as multicopy arrays (20,
31). We were therefore able to address a number of questions with
respect to the role of the DXPas34 locus in regulating
Xist expression and X inactivation by using our
DXPas34 transgenic lines. First, we assessed the effect
of the deletion on Xist expression in undifferentiated ES
cells. A striking phenotype was observed in
DXPas34
transgenic ES cell lines: transcription, both sense and antisense, at
the transgenic Xist locus was found to be abolished, as far
as could be detected by RNA FISH, in all cases. Second, we examined the
capacity of
DXPas34 transgenes to express Xist
RNA following in vitro differentiation. We found that Xist
RNA expression and chromosome coating in cis occurred efficiently at multicopy
DXPas34 transgene loci. Neither
the expression of Xist nor that of the antisense transcripts
prior to differentiation is therefore a requirement for Xist
expression following differentiation. Third, we assessed the ability of
multicopy
DXPas34 loci to induce inactivation of the
endogenous X chromosome (counting) upon differentiation. No evidence
for this was found in the
DXPas34 cell line. Thus,
deletion of DXPas34 may also lead to nonrandom inactivation.
Our results suggest that the DXPas34 locus might contribute
to at least three activities which may or may not be linked: regulation of Xist expression and of antisense transcription prior to
inactivation, and the capacity to induce random inactivation upon differentiation.
DXPas34 may be a developmentally regulated enhancer or
LCR.
The location of DXPas34 3' to Xist and
the disruption of transcriptional activity observed when it is deleted
are both reminiscent of features associated with enhancers
(34). Given the
DXPas34 phenotype,
DXPas34 could be an enhancer of the unstable Xist
transcription found in undifferentiated ES cells. Since both sense and
antisense transcription is disrupted in
DXPas34 mutants,
DXPas34 could be an enhancer affecting the transcriptional
activity of a region of at least 50 kb. Examples of other long-range
enhancers include the locus control region (LCR), which contains
several such elements that enhance transcription across a region of
more than 60 kb (see reference 24 for a review). It
is interesting that low-level intergenic transcription, similar to that
found across the Xist-DXPas34 region and beyond, has also
been found across the LCR and
-globin cluster (1). The
significance of such low levels of transcription is currently unclear.
On the one hand, transcription might be important in, for example,
defining chromatin domains of activity which ensure that genes can be
correctly activated by the appropriate developmental or tissue-specific
factors. On the other hand, such transcription could simply be
symptomatic of an "open" chromatin conformation, mediated by loci
such as LCRs.
A number of experiments could be undertaken to assess further the LCR
or enhancer-like properties of
DXPas34. First, such
elements
should enable high-level expression of linked reporter
genes in
transient-transfection assays. Second, such elements
should be able to
function in an orientation-independent manner
(see reference
34 for a review). Inversion of
DXPas34
should
therefore not alter its ability to enhance
Xist and
antisense
expression. Third, LCRs (but not enhancers) have the capacity
to overcome chromosomal position effects on gene expression in
a
transgenic context. There is already some evidence that
DXPas34 may have this property, since short cosmid
transgenes, which contain
Xist but lack the
DXPas34 locus, show very variable levels of
Xist
expression between lines (
23). Finally, the
DXPas34 locus
would be predicted to contain ES cell-specific
DNase I-hypersensitive
sites and corresponding binding sites for
developmentally regulated
factors.
DXPas34 is associated with low-level antisense
transcription across a large region including Xist.
The existence of a single, ES cell-specific, antisense transcript to
Xist (Tsix), which initiates close to the
DXPas34 locus, has recently been proposed (28).
In our study, we provide evidence for a much more complex transcription
pattern in the region covering Xist and DXPas34.
Complexity was manifested in several ways. First, antisense
transcription was detected across a much larger region than that
reported by Lee et al. (28) and continuous antisense transcripts were found several kilobases 5' of the proposed 5' end of
Tsix. This is probably because we used strand-specific RT-PCR (which appears to be more sensitive than random primed RT-PCR)
to test the whole 50-kb region and not just the Xist-DXPas34 region (28). Second, different levels of transcription were found, with transcription in the Xist-DXPas34 region being
more readily detected than in flanking regions in undifferentiated ES
cells. Unlike Lee et al. (28), we also found evidence of low-level antisense transcription in differentiated ES cells and adult
tissues. A third level of complexity concerns the kinetics of
transcription in this region at the time of X-inactivation initiation.
We found DXPas34 transcripts to be down-regulated on the X
chromosome being inactivated, but down-regulation did not precede the
accumulation of Xist RNA; rather, it coincided with and
sometimes even followed the accumulation of Xist RNA. This
contrasts with the results of Lee et al., who reported that with probes
within (rather than 3' to) Xist, antisense down-regulation was observed just prior to up-regulation of Xist on the
future inactive X (28). This difference could be due to a
slight up-regulation of the sense Xist transcript at the
onset of X inactivation, which might impede efficient antisense
transcript elongation within Xist but not 3' to it.
Alternatively, antisense transcription within Xist and at
the DXPas34 locus might be independently regulated. This
would be consistent with our finding that there are two domains of
low-level antisense transcription in adult somatic cells and differentiated ES cells, one centered over Xist and the
other centered over DXPas34. Taken together, our results
could be reconciled with those of Lee et al. (28) if
DXPas34 did not simply represent the 5' end of a single
"Tsix" transcript but if, instead, several heterogeneous
antisense transcripts existed, initiating at different sites in a large
region 3' to Xist. DXPas34 could be a central regulatory element of this generalized antisense transcription. To
address this, we are investigating the distribution of transcription initiation sites in this large region.
A role for this antisense transcription in regulating
Xist
expression and X inactivation initiation by inhibiting high-levels
of
Xist expression prior to differentiation has been proposed
(
28). Such inhibition might occur either via transcriptional
interference or via transcript stability, since formation of
sense-antisense
RNA duplexes has been suggested to trigger specific
degradation
mechanisms in other organisms (RNA interference)
(
17). If either
of the above were true, abolition of
antisense transcripts, as
seen in our
DXPas34 lines,
would be predicted to lead to higher
levels of
Xist
transcription. However, no sign of
Xist transcription
was
detectable in our
DXPas34 lines. Given this finding,
if antisense
transcription did regulate
Xist expression, a
complex scenario
would have to be envisaged, with
DXPas34
playing two roles with
opposite effects in undifferentiated ES cells:
as an enhancer
of
Xist expression and as a regulator of
antisense transcription,
which itself represses
Xist
expression. A simpler explanation
would be that the low-level antisense
transcription associated
with the presence of
DXPas34 is
just a by-product of the chromatin
conformation needed to mediate the
enhancer-like functions of
this
sequence.
Imprinted DXPas34 transcription during early
development.
DXPas34 was originally identified as a
result of its unusual differential methylation profile (13).
Differential methylation between alleles is also a hallmark of
imprinted genes (see reference 38 for a review). The
expression of DXPas34 during preimplantation development may
well be indicative of a role for this element in the regulation of
imprinted X inactivation and/or the transition from imprinted to random
X inactivation. Although the significance of the transcription itself
remains to be defined, as discussed above, this transcription can
nevertheless be used as a marker for DXPas34 activity.
DXPas34 transcripts are detected on only the maternal, not
the paternal, X chromosome in preimplantation embryos, and the maternal
Xist allele is correspondingly underexpressed. It is not yet
known whether low-level maternal Xist expression at this
stage of embryogenesis is due to transcript instability and/or to
repression of transcription. The fact that expression is seen in only a
proportion of cells suggests that the latter is certainly true. In
cells where maternal Xist expression is observed,
DXPas34 might be acting as an enhancer of unstable, P0-derived Xist transcription, as discussed above in the
context of ES cells, preparing the way for random X inactivation in
embryonic cells. Alternatively, DXPas34 could play a totally
different role in imprinted X inactivation, for example in
preventing high-level Xist expression from the maternal
X chromosome. Clearly, analysis of the Xist expression
phenotype of paternally or maternally inherited
DXPas34
transgenes during embryogenesis will be critical to address this, and
chimeric animals are being created to this end.
Comparison of the
DXPas34 phenotype with other
mutants.
When the phenotype of the DXPas34 deletion is
considered in the light of other deletion mutants and transgenics
generated in this region, it becomes apparent that the Xic is likely to consist of a very complex series of regulatory sequences. For example,
a 35-kb cosmid Xist transgene which does not contain DXPas34 and yet is capable of expressing Xist
prior to differentiation would appear to suggest that
DXPas34 is not an essential regulatory element of
Xist (23, 26). However, the variability in
Xist expression levels between cell lines carrying such
short transgenes suggests that they are susceptible to position effects
(see above) and may have integrated within regions permissive to
transgene expression (as would be predicted, given that they were
subjected to drug selection). Alternatively, since the cosmid contains
only 5 kb of sequence 3' to Xist, it may lack downstream
repressor elements which, in the absence of DXPas34, would
constitutively inhibit Xist expression in the context of
larger transgenes. In another study, deletion of 65 kb of sequence 3'
to Xist and including DXPas34 leads to a
phenotype similar but not identical to the one we have observed. The
Xist RNA signal in this case was reduced but not absent in
undifferentiated ES cells (12). However, given the large
size of the deletion, a number of different regulatory elements may
have been affected in this case. Furthermore, the juxtaposition of the
3' end of an actively transcribed gene (Brx) to the 3' end
of Xist at the deleted locus may actually reconstitute the
wild-type situation of 3' antisense transcription to some extent. In
this context, it would be of interest for both the cosmid transgene and
the 65-kb deletion mutant to determine whether antisense transcription
is present or absent. This could address the question whether
Xist expression prior to differentiation can be uncoupled
from antisense transcription.
The sequences potentially regulating choice and counting in X
inactivation also appear to be diverse. Both the
DXPas34
mutant
reported here and the 65-kb deletion of Clerc and Avner
(
12)
result in nonrandom inactivation of the deleted allele,
suggesting
the presence of elements involved in choice and counting in
this
region. On the other hand, the genetically defined
Xce
locus,
which affects the random nature of X inactivation
(
10), has
been shown to be genetically distinct from
Xist and
DXPas34, lying
distal to them (
37a,
43). Additional elements potentially affecting
choice and
counting have been reported to lie within the
Xist gene
itself (
32). Furthermore, the region upstream of
Xist may
also contain elements involved in counting, since a
120-kb region
5' to
Xist has recently been shown to be
enriched for the hyperacetylated
form of histone H4 in female but not
in male ES cells or in female
ES cells carrying a
Xist
deletion on one of the two X chromosomes
(
35). Indeed, the
data we have presented here suggests that
elements lying 3' to
Xist, such as the
DXPas34 locus, might influence
the choice of X chromosome to be inactivated via their effects
on
transcription initiating upstream of
Xist. The challenge is
now to define whether
DXPas34 controls
Xist
expression through
a direct mechanism, for example as an enhancer which
binds specific
transcription factors, or indirectly, by inducing
wide-range chromatin
conformational changes which could affect
Xist promoter
accessibility.
 |
ACKNOWLEDGMENTS |
We thank C. Fairhead for the gift of YAC mutagenesis plasmids and
helpful advice, N. Brockdorff for the gift of Xist P0
plasmids and primers, C. Morey and P. Clerc for providing
strand-specific Xist RNA FISH probes, and V. Colot for
critical reading of the manuscript.
This work was supported by grants from the Association Française
contre les Myopathies and the Association de Recherche sur le Cancer
and from the Ministère de l'Enseignement Supérieur et de
la Recherche to E.D.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité de
Génétique Moléculaire Murine, URA CNRS 1947, Institut
Pasteur, 25 rue du Docteur Roux, Paris 75015, France. Phone: 33 1 45 68 86 53. Fax: 33 1 45 68 86 56. E-mail: eheard{at}pasteur.fr.
 |
REFERENCES |
| 1.
|
Ashe, H. L.,
J. Monks,
M. Wijgerde,
P. Fraser, and N. J. Proudfoot.
1997.
Intergenic transcription and transinduction of the human beta-globin locus.
Genes Dev.
11:2494-2509[Abstract/Free Full Text].
|
| 2.
|
Avner, P.
1996.
X chromosome inactivation: Xce and the candidate region for the X inactivation centre, p. 249-265.
In
E. Russo, A. Riggs, and R. Martienssen (ed.), Epigenetic mechanisms of gene regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
|
| 3.
|
Avner, P.,
M. Prissette,
D. Arnaud,
B. Courtier,
C. Cecchi, and E. Heard.
1998.
Molecular correlates of the murine Xce locus.
Genet. Res.
72:217-224[Medline].
|
| 4.
|
Beddington, R. S. P.
1987.
Isolation, culture and manipulation of postimplantation mouse embryos.
IRL Press, Oxford, England
|
| 5.
|
Borsani, B.,
R. Tonlorenzi,
M.-C. Simmler,
L. Dandolo,
D. Arnaud,
V. Capra,
M. Grompe,
A. Pizzuti,
D. Muzni,
C. Lawrence,
H. F. Willard,
P. Avner, and A. Ballabio.
1991.
Characterization of a murine gene expressed from the inactive X chromosome.
Nature
351:325-329[Medline].
|
| 6.
|
Brockdorff, N.,
A. Ashworth,
G. F. Kay,
V. M. McCabe,
D. P. Norris,
P. J. Cooper,
S. Swift, and S. Rastan.
1992.
The product of the mouse Xist gene is a 15kb inactive X-specific transcript containing no conserved ORF and located in the nucleus.
Cell
71:515-526[Medline].
|
| 7.
|
Brown, C. J.,
A. Ballabio,
J. L. Rupert,
R. G. Lafrenière,
M. Grompe,
R. Tonlorenzi, and H. F. Willard.
1991.
A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome.
Nature
349:38-44[Medline].
|
| 8.
|
Brown, C. J.,
B. D. Hendrich,
J. L. Rupert,
R. G. Lafrenière,
Y. Xing,
R. G. Lawrence, and H. F. Willard.
1992.
The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus.
Cell
71:527-542[Medline].
|
| 9.
|
Camus, A.,
C. Kress,
C. Babinet, and J. Barra.
1996.
Unexpected behavior of a gene trap vector comprising a fusion between the Sh ble and the lacZ genes.
Mol. Reprod. Dev.
45:255-263[Medline].
|
| 10.
|
Cattanach, B. M., and C. E. Williams.
1972.
Evidence of non-random X-chromosome activity in the mouse.
Genet. Res.
19:229-240[Medline].
|
| 11.
|
Clemson, C. M.,
J. A. McNeil,
H. F. Willard, and J. B. Lawrence.
1996.
XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure.
J. Cell. Biol.
132:259-275[Abstract/Free Full Text].
|
| 12.
|
Clerc, P., and P. Avner.
1998.
Role of the region 3' to Xist exon 6 in the counting process of X-chromosome inactivation.
Nat. Genet.
19:249-253[Medline].
|
| 13.
|
Courtier, B.,
E. Heard, and P. Avner.
1995.
Xce haplotypes show modified methylation in a region of the active X chromosome lying 3' to Xist.
Proc. Natl. Acad. Sci. USA
92:3531-3535[Abstract/Free Full Text].
|
| 14.
|
Debrand, E.,
E. Heard, and P. Avner.
1998.
Cloning and localization of the murine Xpct gene: evidence for complex rearrangements during the evolution of the region around the Xist gene.
Genomics
48:296-303[Medline].
|
| 15.
|
Fairhead, C.,
E. Heard,
D. Arnaud,
P. Avner, and B. Dujon.
1995.
Insertion of unique sites into YAC arms for rapid physical analysis following YAC transfer into mammalian cells.
Nucleic Acids Res.
23:4011-4012[Free Full Text].
|
| 16.
|
Fairhead, C.,
B. Llorente,
F. Denis,
M. Soler, and B. Dujon.
1996.
New vectors for combinational deletions in yeast chromosomes and for gap-repair cloning using `split-maker' recombination.
Yeast
12:1439-1457[Medline].
|
| 17.
|
Grant, S. R.
1999.
Dissecting the mechanisms of posttranscriptional gene silencing: divide and conquer.
Cell
96:303-306[Medline].
|
| 18.
|
Heard, E.,
P. Avner, and R. Rothstein.
1994.
Creation of a deletion series of mouse YACs covering a 500 kb region around Xist.
Nucleic Acids Res.
22:1830-1837[Abstract/Free Full Text].
|
| 19.
|
Heard, E.,
C. Kress,
F. Mongelard,
B. Courtier,
C. Rougeulle,
A. Ashworth,
C. Vourc'h,
C. Babinet, and P. Avner.
1996.
Transgenic mice carrying an Xist-containing YAC.
Hum. Mol. Genet.
5:441-450[Abstract/Free Full Text].
|
| 20.
|
Heard, E.,
F. Mongelard,
D. Arnaud, and P. Avner.
1999.
Xist yeast artificial chromosome transgenes function as X-inactivation centers only in multicopy arrays and not as single copies.
Mol. Cell. Biol.
19:3156-3166[Abstract/Free Full Text].
|
| 21.
|
Heard, E.,
M. C. Simmler,
Z. Larin,
C. Rougeulle,
B. Courtier,
H. Lehrach, and P. Avner.
1993.
Physical mapping and YAC contig analysis of the region surrounding Xist on the mouse X chromosome.
Genomics
15:559-569[Medline].
|
| 22.
|
Heard, H.,
P. Clerc, and P. Avner.
1997.
X-chromosome inactivation in mammals.
Annu. Rev. Genet.
31:571-610[Medline].
|
| 23.
|
Herzing, L. B. K.,
J. T. Romer,
J. M. Horn, and A. Ashworth.
1997.
Xist has properties of the X-chromosome inactivation centre.
Nature
386:272-275[Medline].
|
| 24.
|
Higgs, D. R.
1998.
Do LCRs open chromatin domains?
Cell
95:299-302[Medline].
|
| 25.
|
Hogan, B.,
R. Beddington,
F. Constantini, and E. Lacy.
1994.
Manipulating the mouse embryo: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
|
| 26.
|
Johnston, C. M.,
T. B. Nesterova,
E. J. Formstone,
A. E. Newall,
S. M. Duthie,
S. A. Sheardown, and N. Brockdorff.
1998.
Developmentally regulated Xist promoter switch mediates initiation of X inactivation.
Cell
94:809-817[Medline].
|
| 27.
|
Kay, G. F.,
G. D. Penny,
D. Patel,
A. Ashworth,
N. Brockdorff, and S. Rastan.
1993.
Expression of Xist during mouse development suggests a role in initiation of X chromosome inactivation.
Cell
72:171-182[Medline].
|
| 28.
|
Lee, J. T.,
L. S. Davidow, and D. Warshawsky.
1999.
Tsix, a gene antisense to Xist at the X-inactivation centre.
Nat. Genet.
21:400-404[Medline].
|
| 29.
|
Lee, J. T., and R. Jaenisch.
1997.
Long-range cis effects of ectopic X-inactivation centres on a mouse autosome.
Nature
386:275-278[Medline].
|
| 30.
|
Lee, J. T.,
N. Lu, and Y. Han.
1999.
Genetic analysis of the mouse X inactivation center defines an 80-kb multifunction domain.
Proc. Natl. Acad. Sci. USA
96:3836-3841[Abstract/Free Full Text].
|
| 31.
|
Lee, J. T.,
W. M. Strauss,
J. A. Dausman, and R. Jaenisch.
1996.
A 450 kb transgene displays properties of the mammalian X-inactivation center.
Cell
86:83-94[Medline].
|
| 32.
|
Marahrens, Y.,
J. Loring, and R. Jaenisch.
1998.
Role of the Xist gene in X chromosome choosing.
Cell
92:657-664[Medline].
|
| 33.
|
Marahrens, Y.,
B. Panning,
J. Dausman,
W. Strauss, and R. Jaenisch.
1997.
Xist-deficient mice are defective in dosage compensation but not spermatogenesis.
Genes Dev.
11:156-166[Abstract/Free Full Text].
|
| 34.
|
Marriott, S. J., and J. N. Brady.
1989.
Enhancer function in viral and cellular gene regulation.
Biochim. Biophys. Acta
989:97-110[Medline].
|
| 35.
|
O'Neill, L. P.,
A. M. Keohane,
J. S. Lavender,
V. McKabe,
E. Heard,
P. Avner,
N. Brockdorff, and B. Turner.
1999.
A developmental switch in H4 acetylation upstream of Xist plays a role in X chromosome inactivation.
EMBO J.
18:2897-2907[Medline].
|
| 36.
|
Panning, B.,
J. Dausman, and R. Jaenisch.
1997.
X chromosome inactivation is mediated by Xist RNA stabilization.
Cell
90:907-916[Medline].
|
| 37.
|
Penny, G. D.,
G. F. Kay,
S. A. Sheardown,
S. Rastan, and N. Brockdorff.
1996.
The Xist gene is required in cis for X chromosome inactivation.
Nature
379:131-137[Medline].
|
| 37a.
| Prissette, M., et al. Unpublished data.
|
| 38.
|
Reik, W., and J. Walter.
1998.
Imprinting mechanisms in mammals.
Curr. Opin. Genet. Dev.
8:154-164[Medline].
|
| 39.
|
Robertson, E. J.
1987.
Embryo-derived stem cell lines, p. 71-112.
In
E. J. Robertson (ed.), Teratocarcinomas and embryonic stem cells: a practical approach. IRL Press, Oxford, England
|
| 40.
|
Rose, M. D.,
F. Winston, and P. Hieter.
1990.
Methods in yeast genetics: a laboratory course manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
|
| 41.
|
Rougeulle, C.,
L. Colleaux,
B. Dujon, and P. Avner.
1994.
Generation and characterisation of an ordered lambda clone array for the 460 kb region surrounding the murine Xist sequence.
Mamm. Genome
5:416-423[Medline].
|
| 42.
|
Sheardown, S. A.,
S. M. Duthie,
C. M. Johnston,
A. E. T. Newall,
E. J. Formstone,
R. M. Arkell,
T. B. Nesterova,
G. C. Alghisi,
S. Rastan, and N. Brockdorff.
1997.
Stabilization of Xist RNA mediates initiation of X chromosome inactivation.
Cell
91:99-107[Medline].
|
| 43.
|
Simmler, M. C.,
B. M. Cattanach,
C. Rasberry,
C. Rougeulle, and P. Avner.
1993.
Mapping the murine Xce locus with (CA)n repeats.
Mamm. Genome
4:523-530[Medline].
|
| 44.
|
Simmler, M. C.,
D. B. Cunningham,
P. Clerc,
T. Vermat,
B. Caudron,
C. Cruaud,
A. Pawlak,
C. Szpirer,
J. Weissenbach,
J. M. Claverie, and P. Avner.
1996.
A 94kb genomic sequence 3' to the murine Xist gene reveals an AT rich region containing a new testis specific gene Tsx.
Hum. Mol. Genet.
11:1713-1726.
|
Molecular and Cellular Biology, December 1999, p. 8513-8525, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lee, J. T.
(2009). Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev.
23: 1831-1842
[Abstract]
[Full Text]
-
Morey, C., Kress, C., Bickmore, W. A.
(2009). Lack of bystander activation shows that localization exterior to chromosome territories is not sufficient to up-regulate gene expression. Genome Res
19: 1184-1194
[Abstract]
[Full Text]
-
Navarro, P., Page, D. R., Avner, P., Rougeulle, C.
(2006). Tsix-mediated epigenetic switch of a CTCF-flanked region of the Xist promoter determines the Xist transcription program.. Genes Dev.
20: 2787-2792
[Abstract]
[Full Text]
-
Heard, E., Disteche, C. M.
(2006). Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev.
20: 1848-1867
[Abstract]
[Full Text]
-
Do Kim, J., Hinz, A. K., Bergmann, A., Huang, J. M., Ovcharenko, I., Stubbs, L., Kim, J.
(2006). Identification of clustered YY1 binding sites in imprinting control regions. Genome Res
16: 901-911
[Abstract]
[Full Text]
-
Rowntree, R. K., Lee, J. T.
(2006). Mapping of DNA Replication Origins to Noncoding Genes of the X-Inactivation Center. Mol. Cell. Biol.
26: 3707-3717
[Abstract]
[Full Text]
-
Vigneau, S., Augui, S., Navarro, P., Avner, P., Clerc, P.
(2006). An essential role for the DXPas34 tandem repeat and Tsix transcription in the counting process of X chromosome inactivation. Proc. Natl. Acad. Sci. USA
103: 7390-7395
[Abstract]
[Full Text]
-
Tufarelli, C.
(2006). The silence RNA keeps: cis mechanisms of RNA mediated epigenetic silencing in mammals. Phil Trans R Soc B
361: 67-79
[Abstract]
[Full Text]
-
Navarro, P., Pichard, S., Ciaudo, C., Avner, P., Rougeulle, C.
(2005). Tsix transcription across the Xist gene alters chromatin conformation without affecting Xist transcription: implications for X-chromosome inactivation. Genes Dev.
19: 1474-1484
[Abstract]
[Full Text]
-
Stavropoulos, N., Rowntree, R. K., Lee, J. T.
(2005). Identification of Developmentally Specific Enhancers for Tsix in the Regulation of X Chromosome Inactivation. Mol. Cell. Biol.
25: 2757-2769
[Abstract]
[Full Text]
-
HEARD, E., CHAUMEIL, J., MASUI, O., OKAMOTO, I.
(2004). Mammalian X-Chromosome Inactivation: An Epigenetics Paradigm. Cold Spring Harb Symp Quant Biol
69: 89-102
[Abstract]
-
Nesterova, T. B., Johnston, C. M., Appanah, R., Newall, A. E.T., Godwin, J., Alexiou, M., Brockdorff, N.
(2003). Skewing X chromosome choice by modulating sense transcription across the Xist locus. Genes Dev.
17: 2177-2190
[Abstract]
[Full Text]
-
Shibata, S., Lee, J. T.
(2003). Characterization and quantitation of differential Tsix transcripts: implications for Tsix function. Hum Mol Genet
12: 125-136
[Abstract]
[Full Text]
-
Chureau, C., Prissette, M., Bourdet, A., Barbe, V., Cattolico, L., Jones, L., Eggen, A., Avner, P., Duret, L.
(2002). Comparative Sequence Analysis of the X-Inactivation Center Region in Mouse, Human, and Bovine. Genome Res
12: 894-908
[Abstract]
[Full Text]
-
Luikenhuis, S., Wutz, A., Jaenisch, R.
(2001). Antisense Transcription through the Xist Locus Mediates Tsix Function in Embryonic Stem Cells. Mol. Cell. Biol.
21: 8512-8520
[Abstract]
[Full Text]
-
Maxfield Boumil, R., Lee, J. T.
(2001). Forty years of decoding the silence in X-chromosome inactivation. Hum Mol Genet
10: 2225-2232
[Abstract]
[Full Text]
-
Willard, H. F., Carrel, L.
(2001). Making sense (and antisense) of the X inactivation center. Proc. Natl. Acad. Sci. USA
98: 10025-10027
[Full Text]
-
Park, Y., Kuroda, M. I.
(2001). Epigenetic Aspects of X-Chromosome Dosage Compensation. Science
293: 1083-1085
[Abstract]
[Full Text]
-
Stavropoulos, N., Lu, N., Lee, J. T.
(2001). A functional role for Tsix transcription in blocking Xist RNA accumulation but not in X-chromosome choice. Proc. Natl. Acad. Sci. USA
10.1073/pnas.171243598v1
[Abstract]
[Full Text]
-
Newall, A. E. T., Duthie, S., Formstone, E., Nesterova, T., Alexiou, M., Johnston, C., Caparros, M.-L., Brockdorff, N.
(2001). Primary non-random X inactivation associated with disruption of Xist promoter regulation. Hum Mol Genet
10: 581-589
[Abstract]
[Full Text]
-
Sado, T, Wang, Z, Sasaki, H, Li, E
(2001). Regulation of imprinted X-chromosome inactivation in mice by Tsix. Development
128: 1275-1286
[Abstract]
-
Prissette, M., El-Maarri, O., Arnaud, D., Walter, J., Avner, P.
(2001). Methylation profiles of DXPas34 during the onset of X-inactivation. Hum Mol Genet
10: 31-38
[Abstract]
[Full Text]
-
Okamoto, I, Tan, S, Takagi, N
(2000). X-chromosome inactivation in XX androgenetic mouse embryos surviving implantation. Development
127: 4137-4145
[Abstract]
-
Chao, W., Huynh, K. D., Spencer, R. J., Davidow, L. S., Lee, J. T.
(2002). CTCF, a Candidate Trans-Acting Factor for X-Inactivation Choice. Science
295: 345-347
[Abstract]
[Full Text]
-
Stavropoulos, N., Lu, N., Lee, J. T.
(2001). A functional role for Tsix transcription in blocking Xist RNA accumulation but not in X-chromosome choice. Proc. Natl. Acad. Sci. USA
98: 10232-10237
[Abstract]
[Full Text]